NEWTON, Mass., March 2, 2026 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,…
Read More
Strategic partnership expands Adobe’s service offerings and extends its footprint into Florida, Illinois, and Tennessee PHOENIX, March 2, 2026 /PRNewswire-PRWeb/…
Read More
Prioritizing three key, late-stage clinical programs including Molecular Degrader of Extracellular Proteins (MoDETM) and Targeted Removal of Aberrant Protein (TRAPTM)…
Read More